Work

PACIFICA: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary or Secondary Myelofibrosis and Severe Thrombocytopenia

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-163456

Authors: John Mascarenhas, Aaron T. Gerds, Jean-Jacques Kiladjian, Konstanze Döhner, Sarah Buckley, Jennifer A. Smith, Adam R Craig, Simran Bedi Singh, Srdan Verstovsek, Claire Harrison

Institutions: Icahn School of Medicine at Mount Sinai, Cleveland Clinic, Hôpital Saint-Louis, University Hospital Ulm, CTI BioPharma (United States), The University of Texas MD Anderson Cancer Center, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310106128

FWCI: 2.174

Cites:

Cited by: 17

Related to: 10